Open Nav

Navidea Bio

  • Jed Latkin, Navidea BioPharmaceuticals

Educate the investment community on Navidea

  • Date:Thursday, October 18
  • Time:11:15 AM - 11:30 AM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Publicly Traded Company
  • Company Description/Mission Statement:Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. The Company focuses on the development of innovative immunodiagnostic agents and immunotherapeutics that can and will make a difference for individuals, as well as their families, physicians and care givers, touched by devastating conditions like cancer, autoimmune, infectious and inflammatory diseases. For patients and physicians, we aspire to provide innovative immunodiagnostic agents and therapies to improve patient care for serious diseases.
  • Company Website:
  • Company HQ City:Dublin, Ohio
  • Company HQ Country:United States
  • Company HQ State:Ohio                              
  • Market Cap:$22.5M
  • Ticker:NAVB
  • Exchange:NYSE American
  • CEO/Top Company Official:Jed Latkin
  • Year Founded:1983
  • Main Therapeutic Focus:Diagnostics
  • Lead Product in Development :Manocept™ platform
  • Development Phase of Primary Product:Multiple Products in Market
Jed Latkin
Navidea BioPharmaceuticals